Method for treating cognitive disorders
OwnerNigel Greig, Gosse Bruinsmainventors
Life of this patent
Estimating the term…
Abstract
Compositions and methods for the treatment of diseases resulting from cognitive Disorders, such as Alzheimer's diseases with the compound (−) N-(−)-N phenyl canbamoyleseroline as the active ingredient.
Claims12
A method for treating patients having disease state exhibiting cognitive impairments associated with aging or Alzheimer's disease which comprises administering to a patient having said cognitive impairments a composition containing an active ingredient selected from the group consisting of a compound of the formula:
- 4
- and its pharmaceutically acceptable salt,
- said active ingredient and its salt being administered in an amount effective for retarding the progression of said disease states.
A method for treating patients having disease state exhibits cognitive impairments associated with aging or Alzheimer's disease which comprises administering to a patient having said cognitive impairment a composition containing an active ingredient of the formula
- 5
- and salts thereof,
- said composition being administered orally to provide the active ingredient to the patient a dose of from 0.5 mg to 10 mg/kg per day.
A composition for treating patients having cognitive disorders comprising an active ingredient selected from the group consisting of a compound of the formula
- 6
- and its pharmaceutically acceptable salts,
- and pharmaceutically acceptable carrier suitable for internal administration, said active ingredient being present in an amount suitable for retarding the progression of the disorder.
A composition in unit dosage form for oral administration comprising as an active ingredient a compound of the formula
- 7
- Or its pharmaceutically acceptable salts,
- and a pharmaceutically acceptable carrier suitable for oral administration, said active ingredient being present in an amount of from about 20 to 300 mg.
Dependencies are inferred from the claim text.